Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

15.4%

2 terminated out of 13 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

46%

6 trials in Phase 3/4

Results Transparency

63%

5 of 8 completed with results

Key Signals

5 with results80% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (1)
P 1 (1)
P 3 (3)
P 4 (3)

Trial Status

Completed8
Terminated2
Recruiting2
Not Yet Recruiting1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT03813407Phase 3RecruitingPrimary

An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia

NCT06185660CompletedPrimary

A National, Multicenter, Prospective, Observational Study to Assess Patient Characteristics, Treatment Algorithms and Disease Management of Hyperkalaemia Patients With Chronic Kidney Disease or Under Dialysis or With Heart Failure, Treated With Sodium Zirconium Cyclosilicate in Greece

NCT07307729Not ApplicableNot Yet RecruitingPrimary

AI-Enabled ECG Stratification and Timing of Potassium-Lowering Therapy in Patients With Hyperkalemia: A Target Trial Emulation Study

NCT05347693Phase 4CompletedPrimary

Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study

NCT06858280Phase 3RecruitingPrimary

Patiromer and Diet/hrQoL in Chronic Dialysis

NCT04676646Phase 4CompletedPrimary

Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone

NCT06635499CompletedPrimary

VITALIZE.Use and Effectiveness of Sodium Zirconium Cyclosilicate (LokelmaTM) in the Real-world Setting in Spain

NCT05271266CompletedPrimary

A Multicenter, Prospective, Non-interventional Cohort Study to Evaluate the Safety and Treatment Pattern of Sodium Zirconium Cyclosilicate for Hyperkalaemia Management in Real World Practice in China

NCT05462119CompletedPrimary

Safety of Oral Resin for Treatment of Hyperkalemia in Chinese Patients With Renal Insufficiency

NCT04249648CompletedPrimary

Hyperkalaemia and Its Impact on Therapy with RAASi

NCT04788641Phase 1CompletedPrimary

Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy Subjects

NCT04727528Phase 3TerminatedPrimary

Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease

NCT04997161Phase 4TerminatedPrimary

Study of SZC and Enhanced Nutrition Advice Compared to SoC in Dialysis Patients With Hyperkalaemia

Showing all 13 trials

Research Network

Activity Timeline